Terms: = Colorectal cancer AND FCGR2B, FCGR2, 2213, ENSG00000072694, CD32, CD32B, P31994, IGFR2, FCG2 AND Treatment
7 results:
1. Anti-colon cancer effects of Spirulina polysaccharide and its mechanism based on 3D models.
Lu Y; Chen Z; Lin Q; Xia X; Lin Y; Yan J; Huang M; Huang R
Int J Biol Macromol; 2023 Feb; 228():559-569. PubMed ID: 36581031
[TBL] [Abstract] [Full Text] [Related]
2. Anastomotic leakage following restorative rectal cancer resection: treatment and impact on stoma presence 1 year after surgery-a population-based study.
Eriksen JD; Emmertsen KJ; Madsen AH; Iversen LH
Int J Colorectal Dis; 2022 May; 37(5):1161-1172. PubMed ID: 35469107
[TBL] [Abstract] [Full Text] [Related]
3. Long-term Evaluation of Fistulotomy and Immediate Sphincteroplasty as a treatment for Complex Anal Fistula.
Aguilar-Martínez MDM; Sánchez-Guillén L; Barber-Valles X; Alcaide-Quirós MJ; Bosch-Ramírez M; López-Delgado A; Tozer P; Arroyo A
Dis Colon Rectum; 2021 Nov; 64(11):1374-1384. PubMed ID: 34623349
[TBL] [Abstract] [Full Text] [Related]
4. Acute infusion reactions to chemotherapeutic drugs: a single institute experience.
Muallaoglu S; Disel U; Mertsoylu H; Besen A; Karadeniz C; Taner Sumbul A; Abali H; Ozyilkan O
J BUON; 2013; 18(1):261-7. PubMed ID: 23613414
[TBL] [Abstract] [Full Text] [Related]
5. Biological & physiological aspects of action of insulin-like growth factor peptide family.
Pavelić J; Matijević T; Knezević J
Indian J Med Res; 2007 Apr; 125(4):511-22. PubMed ID: 17598937
[TBL] [Abstract] [Full Text] [Related]
6. Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study.
Ohwada S; Ikeya T; Yokomori T; Kusaba T; Roppongi T; Takahashi T; Nakamura S; Kakinuma S; Iwazaki S; Ishikawa H; Kawate S; Nakajima T; Morishita Y
Br J Cancer; 2004 Mar; 90(5):1003-10. PubMed ID: 14997197
[TBL] [Abstract] [Full Text] [Related]
7. Cytotoxic functions of blood mononuclear cells in patients with colorectal carcinoma treated with mAb 17-1A and granulocyte/macrophage-colony-stimulating factor.
Ragnhammar P; Masucci G; Frödin JE; Hjelm AL; Mellstedt H
Cancer Immunol Immunother; 1992; 35(3):158-64. PubMed ID: 1638551
[TBL] [Abstract] [Full Text] [Related]
